16/05/2014 - 15:05

Phylogica sinks on licensing setback

16/05/2014 - 15:05

Bookmark

Save articles for future reference.

Shares in Subiaco-based biotech firm Phylogica have plummeted on the ASX after a potential licensing deal with a subsidiary of pharmaceutical giant Johnson & Johnson effectively collapsed.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options